← Back to Search

Pericardial insufflation with CO2 for Collapsed lung

N/A
Waitlist Available
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

We use a tiny catheter through the heart to separate the pericardium with gas. We expect this to improve the safety of the Lariat procedure.

Eligible Conditions
  • Collapsed lung
  • Pneumopericardium
  • Cardiac Surgery
  • Atrial Fibrillation
  • Heart mapping
  • Left Atrial Appendage Ligation
  • Pericarditis
  • Left Atrial Appendage Occlusion
  • Cardiac Catheterization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pericardial insufflation with CO2Experimental Treatment1 Intervention
Intentional transatrial introduction of a microcatheter to insufflate the pericardium with carbon dioxide, to separate the walls of the pericardium
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pericardial insufflation with carbon dioxide through a transatrial microcatheter
2014
N/A
~20

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor
309 Previous Clinical Trials
2,168,329 Total Patients Enrolled
~1 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top